Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             74 results found
no title author magazine year volume issue page(s) type
1 Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology Carter, Melody C.
2019
143 3 p. 880-893
article
2 Allergic airway sensitization impairs antibacterial IgG antibody responses during bacterial respiratory tract infections Totten, Arthur H.
2019
143 3 p. 1183-1197.e7
article
3 Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis Takeda, Kazuya
2019
143 3 p. 1163-1175.e15
article
4 Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology Bousquet, Jean
2019
143 3 p. 864-879
article
5 An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos Gignoux, Christopher R.
2019
143 3 p. 957-969
article
6 A novel role for neutrophils in IgE-mediated allergy: Evidence for antigen presentation in late-phase reactions Polak, Dominika
2019
143 3 p. 1143-1152.e4
article
7 A Special Thank-You to Our Reviewers 2019
143 3 p. 914-918
article
8 Autoantibodies to IgE and FcεRI and the natural variability of spleen tyrosine kinase expression in basophils MacGlashan, Donald
2019
143 3 p. 1100-1107.e11
article
9 B lymphocyte–induced maturation protein 1 (Blimp-1), a negative regulator of TH9 development, orchestrates the resolution of airway inflammation in patients with allergic asthma Finotto, Susetta
2019
143 3 p. 937-939
article
10 B lymphocyte–induced maturation protein 1 controls TH9 cell development, IL-9 production, and allergic inflammation Benevides, Luciana
2019
143 3 p. 1119-1130.e3
article
11 Brief Overview of This Month's JACI 2019
143 3 p. A5-A7
article
12 CD3+CD4−CD8− mucosal T cells are associated with uncontrolled chronic rhinosinusitis with nasal polyps Soklic, Tanja Kosak
2019
143 3 p. 1235-1237.e5
article
13 Chronic rhinosinusitis in elderly patients is associated with an exaggerated neutrophilic proinflammatory response to pathogenic bacteria Morse, Justin C.
2019
143 3 p. 990-1002.e6
article
14 Clinical and genetic differences between pustular psoriasis subtypes Twelves, Sophie
2019
143 3 p. 1021-1026
article
15 Complexities in analyzing human basophil responses to autoantibodies to IgE or FcεRI Galli, Stephen J.
2019
143 3 p. 932-934
article
16 Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency Kohn, Donald B.
2019
143 3 p. 852-863
article
17 Continuing Medical Education Calendar 2019
143 3 p. A45-A46
article
18 Corrigendum 2019
143 3 p. 1269
article
19 Corrigendum 2019
143 3 p. 1269
article
20 Cost-effectiveness of diagnostic algorithms for peanut allergy in children Kunst, Natalia R.
2019
143 3 p. 1243-1246
article
21 Cover 1 2019
143 3 p. OFC
article
22 COX-1 mediates IL-33–induced extracellular signal-regulated kinase activation in mast cells: Implications for aspirin sensitivity Pan, Dingxin
2019
143 3 p. 1047-1057.e8
article
23 Developmental regulation of type 1 and type 3 interferon production and risk for infant infections and asthma development Holt, Patrick G.
2019
143 3 p. 1176-1182.e5
article
24 Direct infant UV light exposure is associated with eczema and immune development Rueter, Kristina
2019
143 3 p. 1012-1020.e2
article
25 Editorial Board 2019
143 3 p. A38
article
26 Engineering of structural variants of the major peanut allergens Ara h 2 and Ara h 6 for allergen-specific immunotherapy Bublin, Merima
2019
143 3 p. 1226-1229.e10
article
27 Eosinophil progenitor levels correlate with tissue pathology in pediatric eosinophilic esophagitis Schwartz, Justin T.
2019
143 3 p. 1221-1224.e3
article
28 Epicutaneous immunotherapy for peanut allergy modifies IgG4 responses to major peanut allergens Koppelman, Stef J.
2019
143 3 p. 1218-1221.e4
article
29 Expression of corticosteroid-regulated genes by PBMCs in children with asthma Goleva, Elena
2019
143 3 p. 940-947.e6
article
30 Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergy Orgel, Kelly
2019
143 3 p. 1027-1037.e7
article
31 Histologic similarities in children with eosinophilic esophagitis and proton pump inhibitor–responsive esophageal eosinophilia Nguyen, Nathalie
2019
143 3 p. 1237-1240.e2
article
32 Human cystatin SN is an endogenous protease inhibitor that prevents allergic rhinitis Fukuoka, Ayumi
2019
143 3 p. 1153-1162.e12
article
33 Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition Zhang, Yuan
2019
143 3 p. 1108-1118.e4
article
34 Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation Takamori, Ayako
2019
143 3 p. 1231-1235.e12
article
35 IgE-class–specific immunosuppression in offspring by administration of anti-IgE to pregnant mice Morita, Hideaki
2019
143 3 p. 1261-1264.e6
article
36 Immunologic reconstitution following hematopoietic stem cell transplantation despite lymph node paucity in NF-κB–inducing kinase deficiency Ben Farhat, Khaoula
2019
143 3 p. 1240-1243.e4
article
37 Increased eosinophil uptake in the lungs of obese patients with asthma—to correct for obesity compared to obese controls van Huisstede, Astrid
2019
143 3 p. 1265
article
38 Indirect treatment comparison of asthma biologics fraught with methodology issues Bourdin, Arnaud
2019
143 3 p. 1266-1267
article
39 Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy Moldaver, Daniel M.
2019
143 3 p. 1087-1099.e4
article
40 Information for Readers 2019
143 3 p. A40
article
41 Interlaboratory variability in multiplexed pneumococcal antibody testing LaFon, David C.
2019
143 3 p. 1255-1257
article
42 Molecular diagnosis for allergen immunotherapy Matricardi, Paolo Maria
2019
143 3 p. 831-843
article
43 Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy Shamji, Mohamed H.
2019
143 3 p. 1067-1076
article
44 Neuroplastic changes in the olfactory bulb associated with nasal inflammation in mice Hasegawa-Ishii, Sanae
2019
143 3 p. 978-989.e3
article
45 New insights into the utility of omalizumab Cardet, Juan Carlos
2019
143 3 p. 923-926.e1
article
46 News Beyond Our Pages Rothenberg, Marc E.
2019
143 3 p. 921-922
article
47 News & Notes 2019
143 3 p. A42-A44
article
48 Novel locus for atopic dermatitis in African Americans and replication in European Americans Almoguera, Berta
2019
143 3 p. 1229-1231
article
49 Novel vaccines: Technology and development Patil, Sarita U.
2019
143 3 p. 844-851
article
50 Ordinary vibratory angioedema is not generally associated with ADGRE2 mutation Zhao, Zuotao
2019
143 3 p. 1246-1248.e4
article
51 Paraben exposures and asthma-related outcomes among children from the US general population Quirós-Alcalá, Lesliam
2019
143 3 p. 948-956.e4
article
52 Peak flow variability in childhood and body mass index in adult life Lombardi, Enrico
2019
143 3 p. 1224-1226.e9
article
53 Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles Suárez-Fariñas, Mayte
2019
143 3 p. 1038-1046
article
54 Predicting steroid responsiveness in asthmatic children: Are we there yet? Sly, Peter D.
2019
143 3 p. 927-928
article
55 Prenatal 25-hydroxyvitamin D deficiency affects development of atopic dermatitis via DNA methylation Cho, Hyun-Ju
2019
143 3 p. 1215-1218
article
56 Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology Dietz de Loos, Dirk
2019
143 3 p. 1207-1214
article
57 Reply Farahi, Neda
2019
143 3 p. 1265-1266
article
58 Reply Gunsoy, Necdet B.
2019
143 3 p. 1267-1268
article
59 Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions” Davidson, Wendy F.
2019
143 3 p. 894-913
article
60 Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes Togias, Alkis
2019
143 3 p. 1003-1011.e10
article
61 Role of Der p 1–specific B cells in immune tolerance during 2 years of house dust mite–specific immunotherapy Boonpiyathad, Tadech
2019
143 3 p. 1077-1086.e10
article
62 Role of IL-35 in sublingual allergen immunotherapy Shamji, Mohamed H.
2019
143 3 p. 1131-1142.e4
article
63 Role of P2X3 receptors in scratching behavior in mouse models Shiratori-Hayashi, Miho
2019
143 3 p. 1252-1254.e8
article
64 Selection of house dust mite–allergic patients by molecular diagnosis may enhance success of specific immunotherapy Chen, Kuan-Wei
2019
143 3 p. 1248-1252.e12
article
65 Soil exposure modifies the gut microbiota and supports immune tolerance in a mouse model Ottman, Noora
2019
143 3 p. 1198-1206.e12
article
66 Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma Pfaar, Oliver
2019
143 3 p. 970-977
article
67 Table of Contents 2019
143 3 p. A8, A10-A11, A16-A19, A23-A24, A26-A28, A30-A32
article
68 The Editors' Choice Ballas, Zuhair K.
2019
143 3 p. 919-920
article
69 The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial Biedermann, Tilo
2019
143 3 p. 1058-1066.e6
article
70 TH9 immunodeficiency in patients with hyper-IgE syndrome Olson, Matthew R.
2019
143 3 p. 935-936
article
71 Understanding differences in allergen immunotherapy products and practices in North America and Europe Mahler, Vera
2019
143 3 p. 813-828
article
72 Understanding differences in allergen immunotherapy products and practices in North America and Europe 2019
143 3 p. 829-830
article
73 Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms Campana, Raffaela
2019
143 3 p. 1258-1261
article
74 Vitamin D is no substitute for the sun Matsushima, Yoshiaki
2019
143 3 p. 929-931
article
                             74 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands